跳至主要内容
临床试验/NCT07369648
NCT07369648招募中不适用

Effects of Repetitive Transcranial Magnetic Stimulation Combined With Motor Rehabilitation on Motor and Functional Outcomes in Patients With Ischemic Stroke: A Randomized Sham-Controlled Trial

Hanoi Medical University1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2026年2月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
66
试验地点
1
主要终点
Change in upper limb motor function assessed by the Fugl-Meyer Assessment for Upper Extremity (FMA-UL)

研究概览

简要总结

Ischemic stroke is a leading cause of long-term motor disability, frequently resulting in hemiplegia and limitations in daily activities and quality of life. Motor rehabilitation is a fundamental component of post-stroke care across all stages of recovery; however, functional outcomes may vary, particularly in patients with persistent motor impairment.

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique that has been used as an adjunct to rehabilitation to modulate cortical excitability and potentially support motor recovery.

The purpose of this study is to evaluate the effects of low-frequency rTMS combined with conventional motor rehabilitation compared with sham rTMS combined with conventional motor rehabilitation in patients with first-ever ischemic stroke during the acute, subacute, and chronic stages. Motor function, balance, functional mobility, activities of daily living, and stroke-specific quality of life will be assessed at baseline, after the intervention, and at 3-month and 6-month follow-up.

详细描述

This study is a randomized, sham-controlled clinical trial designed to evaluate the outcomes of repetitive transcranial magnetic stimulation (rTMS) combined with motor rehabilitation in patients with first-ever ischemic stroke presenting with hemiplegia.Participants will be recruited during the acute (< 1 month), subacute (1-6 months), and chronic (> 6 months) stages after stroke onset.

Eligible participants will be allocated into two groups: a control group and an intervention group. Both groups will receive standardized conventional motor rehabilitation targeting upper and lower limb motor function, balance, and functional mobility.

In the intervention group, participants will receive low-frequency rTMS in addition to conventional motor rehabilitation. rTMS will be delivered at a frequency of 1 Hz, once daily, five days per week, for a total of 20 sessions. For upper limb rehabilitation, stimulation will be applied to the primary motor cortex (M1) corresponding to the hand area of the contralesional hemisphere using a figure-of-eight coil. For lower limb rehabilitation, stimulation will target the leg area of M1 located in the medial interhemispheric region using a Hesed coil. Stimulation intensity will be set relative to each participant's motor threshold, and rTMS sessions will be administered immediately prior to motor rehabilitation.

In the control group, participants will receive sham rTMS combined with the same conventional motor rehabilitation program. Sham stimulation will be performed using identical procedures, participant positioning, coil placement, stimulation duration, and acoustic output as the active rTMS condition. To minimize cortical stimulation, the coil will be positioned perpendicular to the scalp, producing minimal magnetic field penetration while maintaining the characteristic clicking sound of the device.

To ensure blinding, participants will not be informed of their group allocation, and they will be instructed not to disclose any information related to the intervention they received prior to outcome assessments. Outcome assessors will be blinded to group assignment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Participants are blinded using sham repetitive transcranial magnetic stimulation, in which the procedure, coil positioning, stimulation duration, and acoustic cues are identical to the active intervention, while the coil is positioned perpendicular to minimize cortical stimulation. Outcome assessors are blinded to group allocation and are not involved in participant recruitment, randomization, or intervention delivery. Assessments are conducted in a separate room and at different time points from the intervention sessions. In case of unintended unblinding, the assessor is replaced and the incident is documented.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 18 to 80 years.
  • Diagnosed with a first-ever ischemic stroke, confirmed by neuroimaging.
  • Presence of unilateral hemiparesis attributable to the first-ever ischemic stroke.
  • Time since stroke onset:
  • Acute stage: < 1 month after stroke onset
  • Subacute stage: 1 to 6 months after stroke onset
  • Chronic stage: > 6 months after stroke onset
  • Moderate neurological impairment, defined as a baseline NIHSS score between 5 and
  • Cognitive ability sufficient to understand and follow instructions, indicated by a baseline MMSE score ≥
  • Medically stable and able to participate in a structured motor rehabilitation program.
  • Provided written informed consent prior to study enrollment.
  • NIHSS and MMSE scores are assessed at baseline only to characterize neurological severity and cognitive status at study entry

排除标准

  • Motor impairment caused by conditions other than ischemic stroke, such as musculoskeletal disorders, traumatic brain injury, Parkinson's disease, encephalitis, or other neurological conditions.
  • Contraindications to repetitive transcranial magnetic stimulation, including but not limited to intracranial metallic implants, implanted electronic medical devices (e.g., pacemaker), cochlear implants, known bleeding disorders, pregnancy, history of epilepsy or seizure disorders, severe cardiac disease, severe psychiatric or neurological disorders interfering with participation, or active skin conditions at the stimulation site.
  • History of epilepsy or seizure disorders.
  • Recurrent stroke occurring during the intervention period.
  • Refusal to participate, withdrawal of informed consent, or non-adherence to the intervention protocol.

研究组 & 干预措施

Control Group

Placebo Comparator

Participants receive sham rTMS combined with the same standardized conventional motor rehabilitation program. Sham stimulation uses identical procedures, participant positioning, coil placement, session duration, and acoustic cues as active rTMS, but with the coil oriented perpendicular to the scalp to minimize effective cortical stimulation

干预措施: Sham repetitive transcranial magnetic stimulation (Device)

Control Group

Placebo Comparator

Participants receive sham rTMS combined with the same standardized conventional motor rehabilitation program. Sham stimulation uses identical procedures, participant positioning, coil placement, session duration, and acoustic cues as active rTMS, but with the coil oriented perpendicular to the scalp to minimize effective cortical stimulation

干预措施: Conventional motor rehabilitation (Other)

Intervention Group

Experimental

Participants receive active low-frequency repetitive transcranial magnetic stimulation (rTMS) combined with standardized conventional motor rehabilitation targeting both upper and lower limb function. Active rTMS targets the primary motor cortex (M1) representations relevant to the upper limb (hand area) and lower limb (leg area), with stimulation parameters delivered according to the predefined protocol.

干预措施: Active repetitive transcranial magnetic stimulation (Device)

Intervention Group

Experimental

Participants receive active low-frequency repetitive transcranial magnetic stimulation (rTMS) combined with standardized conventional motor rehabilitation targeting both upper and lower limb function. Active rTMS targets the primary motor cortex (M1) representations relevant to the upper limb (hand area) and lower limb (leg area), with stimulation parameters delivered according to the predefined protocol.

干预措施: Conventional motor rehabilitation (Other)

结局指标

主要结局

Change in upper limb motor function assessed by the Fugl-Meyer Assessment for Upper Extremity (FMA-UL)

时间窗: Baseline, immediately after the 4-week intervention period, and at 3-month and 6-month follow-up

The Fugl-Meyer Assessment for Upper Extremity (FMA-UL) is a validated scale for evaluating motor impairment of the upper limb after stroke. Scores range from 0 to 66, with higher scores indicating better motor function.

次要结局

  • Change in manual dexterity assessed by the Box and Block Test (BBT)(Baseline, immediately after the 4-week intervention period, and at 3-month and 6-month follow-up)
  • Change in functional mobility assessed by the Timed Up and Go test (TUG)(Baseline, immediately after the 4-week intervention period, and at 3-month and 6-month follow-up)
  • Change in balance performance assessed by the Berg Balance Scale (BBS)(Baseline, immediately after the 4-week intervention period, and at 3-month and 6-month follow-up)
  • Change in activities of daily living assessed by the modified Barthel Index (mBI)(Baseline, immediately after the 4-week intervention period, and at 3-month and 6-month follow-up)
  • Change in quality of life assessed by the Stroke-Specific Quality of Life Scale (SS-QoL)(Baseline, immediately after the 4-week intervention period, and at 3-month and 6-month follow-up)

研究者

发起方
Hanoi Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验